Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
University Hospital, Angers
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Geron Corporation
Incyte Corporation
PharmaEssentia
Cellenkos, Inc.
Mayo Clinic
Astex Pharmaceuticals, Inc.
OHSU Knight Cancer Institute
Centre Hospitalier Universitaire de Nīmes
Ascentage Pharma Group Inc.
Sierra Oncology LLC - a GSK company
Novartis
M.D. Anderson Cancer Center
Incyte Corporation
Galena Biopharma, Inc.
Northwestern University